Tests Clostridium butyricum Miyairisan for symptoms of Parkinson's disease
Tests a probiotic drug in adults with Parkinson's disease, for movement and other symptoms.
Plain-language title generated from the registry record
Registry title: The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
Key facts
- Where
- Kaohsiung City, TaiwanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 90 years old?
Source: NCT06548256, who can take part
Where in Taiwan
- Kaohsiung Medical Univeristy HospitalKaohsiung City, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Trial code
- NCT06548256
- Record updated
- 12 August 2024
- Original description
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's diseaseRead full original descriptionShow less
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Inclusion: Male or female over 20 years old, diagnosed with Parkinson's disease.
Exclusion: People with Parkinson's disease Dementia, or Lactose Intolerance.